Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Biosimilars lower costs but don't significantly improve access.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

These medications for BPH have known risks and may have new side effects.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Chitosan-coated spironolactone nano carriers effectively treat acne without side effects.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

GnRH treatment can reduce breast cancer cell invasion.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Finasteride reduced seizures and prevented cognitive issues in rats after neonatal asphyxia but increased anxiety later.

Mutations in certain receptors can cause diseases and offer new treatment options.

Finasteride and dutasteride may increase the risk of suicide and sexual dysfunction.

Finasteride's sexual side effects may be due to nocebo effect.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.